Treatment

October 27, 2025

2025/2026 Medicare Update

Kevin Lawrence
Presenter
Kevin Lawrence
Title
Director of Medicare Sales
Professional Group Plans
(PGP Benefits)
Jason Harris
Moderator
Jason Harris
Title
Vice President of Government Relations and Advocacy, NPF

After viewing this webinar, please provide your feedback by taking our short questionnaire to let us know what you think about the presentation and content. We’d love to hear from you!

View this webinar as Kevin Lawrence, Director of Medicare Sales from Professional Group Plans, and moderator Jason Harris, NPF Vice President of Government Relations and Advocacy, discuss:

  • Medicare Basics for Parts A, B, C (combination plans) and D for drug benefits, what’s covered and not covered on the basic plan vs the Advantage or combination plans.
  • Expected monthly premiums by income.
  • Medication costs, including the cap on out-of-pocket expenses for 2025 and 2026 and the option to be billed by month in the Medicare Payment Plan for medications.
  • Where to obtain assistance if needed through “Extra Help” programs.
  • Part D penalties and when they apply.

Hear what you need to know during this open enrollment period, which ends December 7, 2025. Get the advice you need up front before signing up.

Additional resources:

  • Listen to “Let’s Talk: Know Your Medicare Options and What Changes Mean for You” to hear Kim Beer, Senior Vice President of Policy and External Affairs with the National Health Council, dermatologist Dr. Jeffrey Cohen, Director of the Psoriasis Treatment Program at Yale University School of Medicine, and Jason Harris, Vice President of Government Relations and Advocacy at NPF discuss what Medicare changes occurred in 2025 that impact psoriatic disease care, outcomes to date, what’s to come in 2026, and what you should consider when choosing health care plans during open enrollment.
  • For more information and resources, access our Medicare Resource Hub.

This webinar is brought to you with support from our presenting sponsor:

Novartis logo
Share
Related Items

Stay in the Know

Expert tips, can’t-miss events, and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity Navigator

Copyright © 1996-2025 National Psoriasis Foundation/USA


The National Psoriasis Foundation is a qualified 501(c)(3) EIN 93-0571472.


Duplication, rebroadcast, republication, or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.